AstraZeneca

AstraZeneca

featured image of Unlocking Bioprocessing: How Ontologies Boost Efficiency!

Unlocking Bioprocessing: How Ontologies Boost Efficiency!

BIOT

🌟 Discover how ontologies enhance communication in bioprocessing, boosting efficiency and interoperability for leading companies like AstraZeneca! 🔗🏭🛠️

featured image of AstraZeneca's $2 Billion Boost for Maryland Jobs!

AstraZeneca’s $2 Billion Boost for Maryland Jobs!

BIOT

🌟 AstraZeneca invests $2 billion in Maryland! 🏭 Expanding facilities, creating 2,600 jobs, and focusing on rare diseases! 🔬🌱✨

Boosting Antibody Production: Speed and Scalability Secrets!

BIOT

🚀 Discover advancements in upstream bioprocessing for monoclonal and bispecific antibodies! 💉 Enhance speed and scalability for efficient production!

featured image of AstraZeneca Unveils $300M Game-Changer for Cell Therapy

AstraZeneca Unveils $300M Game-Changer for Cell Therapy

BIOT

AstraZeneca's new $300M plant in Rockville enhances CAR T therapy production, ensuring high-quality, patient-specific treatments! 🌟🏭💡🔍 CellTherapy

featured image of AstraZeneca Joins Obesity Market with $30m Investment

AstraZeneca Joins Obesity Market with $30m Investment

BIOT

📢 Swiss obesity start-up SixPeaks Bio secures $30m, partners with AstraZeneca to develop potential obesity treatment. 💪💊🍔 ObesityMarket Collaboration

featured image of AstraZeneca Buys Fusion Therapeutics for $2 Billion Revolutionizing Cancer Treatment

AstraZeneca Buys Fusion Therapeutics for $2 Billion Revolutionizing Cancer Treatment

BIOT

🔬 AstraZeneca is acquiring Fusion Therapeutics Inc for $2 billion upfront to transform cancer treatment with targeted therapies. 💰🌟

featured image of AstraZeneca Acquires Amolyt Pharma for $105bn!

AstraZeneca Acquires Amolyt Pharma for $105bn!

BIOT

📢 AstraZeneca to acquire Amolyt Pharma for $1.05bn 💼💰 with $800m upfront and potential milestone payments of $250m. Amazing news for biotech in France and Europe!

featured image of AZ Accelerates Cell Therapy Production with FasTCAR: Faster Cheaper and Accessible

AZ Accelerates Cell Therapy Production with FasTCAR: Faster Cheaper and Accessible

BIOT

📢 AstraZeneca teams up with FasTCAR to fast-track cell therapy production, revolutionizing accessibility and affordability for patients. 🚀

featured image of AstraZeneca's $300M Expansion Ignites Cell and Gene Therapy Revolution

AstraZeneca’s $300M Expansion Ignites Cell and Gene Therapy Revolution

BIOT

AstraZeneca invests $300m in new research facility in Cambridge, UK to advance cell and gene therapies. 💉🔬💼🔍👥

featured image of AstraZeneca Seeks UK Gov Aid to Boost Vaccine Production

AstraZeneca Seeks UK Gov Aid to Boost Vaccine Production

BIOT

📰 AstraZeneca wants UK Gov aid to expand vaccine plant 💸 The pharmaceutical company seeks financial support to boost production capacity. 💉

12 Next